Sumathi Nambiar
Johnson & Johnson (United States)
ORCID: 0000-0002-3124-1689Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials”.
Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +12 more
Ramya Gopinath, Ursula Waack, Mark Needles, Daniel L. Rubin, Deborah Collyar +11 more
Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +24 more
Shukal Bala, James M. Byrne, Kerian Grande Roche, Seong H. Jang, Peter Kim +30 more